Please Wait
Applying Filters...
menu
    • menu
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    Data Compilation
    #PharmaFlow

    Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

    Stock Recap
    #PipelineProspector

    Menu

    Rifoldin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 205Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    04/06/2025 Lupin Ltd
    India
    		 M/s Lupin Ltd WC-0201 Rifampicin EP/BP/USP 2022-09-30 2025-09-10 T-142, MIDC, Tarapur, Boisar, Palghar - 401506, Maharashtra, India
    30/06/2025 Olon S.p.A
    Italy
    		 MIs. Olon Active Pharmaceutical Ingredients India Private Limited WC-0197 Rifampicin IP/BP/EP 2022-09-16 2025-09-08 Plot No. L-1, L-21 to L-28 & L-44, Additional Phase MIDC, Mahad, Taluka: Mahad, District: Raigad-402301.